Refine by
Applications
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Diagnostic Solutions for Lung Cancer
- Liquid Biopsy Solutions for Breast Cancer
- Diagnostic Solutions for Colorectal Cancer
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Drug Dolution for Liver Metastases
- Drug Dolution for Gastric Cancer
- microbiota for Clinical Studies
- Actionable Molecular Diagnostic System for Physicians
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Nuclear Medicine for Therapy
- Nuclear Medicine for Theragnostics
Cancer Cell Equipment & Supplies
1,271 equipment items found
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
Images taken using a Nikon Eclispe C1 confocal microscope. HepG2 liver cells were grown for 21 days in the Mimetix scaffold. Cells are stained with DAPI and actin; fibres are electrospun together with Rhodamine 6G (a and b). Cancer cells form a 3D network inside the scaffold (c), use the fibres to support themselves (d) and ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation depth of MCF7 breast cancer cells in the Mimetix scaffold after 4 days of culture (nuclei stained with TO-PRO-3, blue). The video below shows a Z-stack (slices ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
The mechanism of action of Bria-IMT™/Bria-OTS™ is currently under investigation. We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We hypothesize that Bria-IMT™/Bria-OTS™, exert their action by stimulating the antigen-presentation system (i.e. the system that presents antigen material on ...
Manufactured by:Filtricine, Inc. based inSanta Clara, CALIFORNIA (USA)
The hyperactive metabolism of cancer cells is extensively modified to support their unsustainable consumption of nutrients, which is what allows cancer cells to reproduce rapidly. Yet cancer cells lose their ability to make certain nutrients on their own like healthy cells do. ...
Manufactured by:Mol Scientific based in, CHINA
Mol Scientific offer high-quality Cancer cell proliferation inhibitor peptide product(MPE0003430). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly competitive prices. ...
Manufactured by:Filtricine, Inc. based inSanta Clara, CALIFORNIA (USA)
Filtricine’s Innovative Technology Restricts Nutritional Support to Cancer Cells. Our strategy is to eliminate cancer cells’ access to non-essential amino acids, which the cancer cells require for growth. Our first technology is used in the development of exclusive replacement meals ...
Manufactured by:OncoVITA based inParis, FRANCE
Oncovita’s MeasovirTM proprietary platform relies on a DNA plasmid vector that expresses a modified measles Schwarz virus antigenome able to generate recombinant viruses by using a clonal reverse genetics system. This versatile plug-and-play platform allows producing new viruses expressing very large amounts of additional genetic ...
by:Cymit Química S.L. based inBarcelona, SPAIN
4-Methylumbelliferyl lignocerate is a synthetic fatty acid that inhibits the growth of cancer cells. It has been shown to have an inhibitory effect on breast cancer cell lines, such as MDA-MB-231 and MCF-7. ...
Manufactured by:SystImmune Inc. based inRedmond, WASHINGTON (USA)
This advanced functional class is referred to as Heterogeneity overcoming - Immunogenic death inducing - Resistance antagonizing - Enhanced Specificity (HIRE) molecules that target cancer cells. While HIRE molecules provide cancer cells specific targeting, and exert bi-modal proliferative inhibition, any cancer ...
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
CP 31398 dihydrochloride is a p53 stabilizer which stabilizes the active conformation of p53 and promotes p53 activity in cancer cell lines with mutant or wild-type ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Pladienolide B is a highly potent splicing inhibitor of both hypoxia signals and cancer cell ...
Manufactured by:Kinomica based inMacclesfield, UNITED KINGDOM
Kinomica have used KScan®, a much more accurate way to predict whether an Acute myeloid leukaemia patient will respond to midostaurin. KScan® involves measuring the simultaneous activity of kinases within a patient’s cancer cells. This readout can then better predict whether midostaurin will destroy those ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Thymosin β15 is a small actin-binding protein upregulated in highly metastatic rat prostate cancer cells, relative to low metastatic cells.http://www.creative-peptides.com/product/thymosin-item-10-101-100-109.html ...
Manufactured by:Biosceptre International Limited based inCambridge, UNITED KINGDOM
CAR T-cell therapy is the engineering of a patient’s T cells, a type of white blood cell. A small portion of these cells are collected, from a patient’s blood sample, and re-engineered to produce chimeric antigen receptors (CAR’s) on the cell surface. The chimeric antigen receptors give T ...
by:Astraveus based inParis, FRANCE
In healthy patients T cells detect and kill sick cells. Cancer cells escape T cells recognition thanks to mutations. CAR-T cells (T cells equipped with a Chimeric Antigen Receptor) are artificially hardcoded to recognize and kill cancer cells. ...
Manufactured by:SystImmune Inc. based inRedmond, WASHINGTON (USA)
This Specificity Enhanced Bi-specific Antibody (SEBA) is of the oncology therapeutic class that bind functional proteins on the surface of cells, in this molecule to block growth signals that cancer cells depend on for survival. The SEBA technology allows the molecule to use one surface protein for specific targeting of the ...
Manufactured by:Curasight based inKøbenhavn N, DENMARK
Curasight's uTREAT is new type of targeted radiation therapy, targeting and irradiating the cancer cells and almost not healthy tissue. By injecting a substance that seeks all cancer cells, including the metastases that are far away from the primary tumour, this offers a personalised and tailored therapy to each ...
Manufactured by:Valeo Pharma Inc. based inKirkland, QUEBEC (CANADA)
It exerts its anticancer effects primarily by inhibiting active transcription, a type of gene expression on which proliferating cancer cells are particularly ...
Manufactured by:Hebei Mirun Import and Export Trading Co., Ltd based inMinhang District, CHINA
Short Description: Ropivacaine hydrochloride monohydrate has been used as an analyte in tandem mass spectrometry and as an amide-based local anaesthetic to test its effect on breast cancer cell methylation. ...
by:Da Zen Theranostics, Inc. based inSilicon Valley, CALIFORNIA (USA)
Da Zen’s products and technologies deliver targeted anticancer drugs, such as simvastatin and cisplatin conjugated to a cancer targeting dye-carrier, exclusively to cancer cells, with the drugs confined to the cancer cells for much longer than current therapies (up to three to four weeks) and no evidence of ...